Evidence map›Paper›PMID 35928387›Full record

ArticleClinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology2022

Clinical guidelines for the diagnosis and treatment of 21-hydroxylase deficiency (2021 revision).

Tomohiro Ishii, Kenichi Kashimada, Naoko Amano, Kei Takasawa, Akari Nakamura-Utsunomiya, Shuichi Yatsuga, Tokuo Mukai, Shinobu Ida, Mitsuhisa Isobe, Masaru Fukushi and 5 more

Open access · diamondAbstract read
In one paragraph

Article in Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Guideline
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Clinical practice guidelines for the management of differences of sex development in Japan.Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology · 2026
    Review
  7. Hydrocortisone dosage at 3 years of age is positively correlated with body mass index at 10 years in individuals with 21-hydroxylase deficiency.Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology · 2026
    Article
  8. Article
  9. Article
  10. Newborn screening for congenital adrenal hyperplasia: Utility of liquid chromatography with tandem mass spectrometry as a secondary test.Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology · 2025
    Review
  11. Adrenal crisis during a trip in a young child with septo-optic dysplasia.Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 12 institutions in 4 countries.

Tomohiro IshiiDifferences of Sex Development (DSD) and Adrenal Disorders Committee, Japanese Society for Pediatric Endocrinology.
Kenichi KashimadaDifferences of Sex Development (DSD) and Adrenal Disorders Committee, Japanese Society for Pediatric Endocrinology.
Naoko AmanoDepartment of Pediatrics, Keio University School of Medicine, Tokyo, Japan.
Kei TakasawaDepartment of Pediatrics and Developmental Biology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
Akari Nakamura-UtsunomiyaCommittee on Mass Screening, Japanese Society for Pediatric Endocrinology.
Shuichi YatsugaCommittee on Mass Screening, Japanese Society for Pediatric Endocrinology.
Tokuo MukaiDifferences of Sex Development (DSD) and Adrenal Disorders Committee, Japanese Society for Pediatric Endocrinology.
Shinobu IdaDifferences of Sex Development (DSD) and Adrenal Disorders Committee, Japanese Society for Pediatric Endocrinology.
Mitsuhisa IsobeJapanese Society for Neonatal Screening.
Masaru FukushiJapanese Society for Neonatal Screening.
Hiroyuki SatohJapanese Society for Pediatric Urology.
Kaoru YoshinoJapanese Society for Pediatric Urology.
Michio OtsukiJapan Endocrine Society.
Takuyuki KatabamiJapan Endocrine Society.
Toshihiro TajimaCommittee on Mass Screening, Japanese Society for Pediatric Endocrinology.
Society for Endocrinology · GBKeio University · JPChildren's Medical Center · IRHiroshima Prefectural Hospital · JPJapanese Red Cross Asahikawa Hospital · JPOsaka Women's and Children's Hospital · JPSaitama Prefecture · JPSapporo Science Center · JPThe University of Tokyo · JPTokyo Metropolitan Children's Medical Center · JPTokyo Women's Medical University · JPYokohama City Seibu Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Congenital adrenal hyperplasia is a category of disorders characterized by impaired adrenocortical steroidogenesis. The most frequent disorder of congenital adrenal hyperplasia is 21-hydroxylase deficiency, which is caused by pathogenic variants of

Indexed as

21-hydroxylase deficiencycongenital adrenal hyperplasiaguidelineneonatal mass screening

Identifiers

PMID35928387
PMCPMC9297175
OpenAlexW4226383464

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.